Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study

Pfohler, C, Cree, IA, Ugurel, S, Kuwert, C, Haass, N, Neuber, K, Hengge, U, Corrie, PG, Zutt, M, Tilgen, W and Reinhold, U (2003) Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anti-Cancer Drugs, 14 5: 337-340. doi:10.1097/01.car.0000070764.25457.ca


Author Pfohler, C
Cree, IA
Ugurel, S
Kuwert, C
Haass, N
Neuber, K
Hengge, U
Corrie, PG
Zutt, M
Tilgen, W
Reinhold, U
Title Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study
Journal name Anti-Cancer Drugs   Check publisher's open access policy
ISSN 0959-4973
Publication date 2003-06-01
Year available 2003
Sub-type Article (original research)
DOI 10.1097/01.car.0000070764.25457.ca
Volume 14
Issue 5
Start page 337
End page 340
Total pages 4
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language eng
Keyword chemotherapy
choroidal melanoma
gemcitabine
treosulfan
Ex-Vivo Chemosensitivity
Ocular Melanoma
Choroidal Melanoma
Prognostic Factors
Chemotherapy
Liver
Therapy
Cancer
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: WoS Import - Archived
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 26 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 02 Jun 2014, 10:12:54 EST by Nikolas Haass